文档介绍：Alpharma: New Platform for Growth
March 21, 2006 Four Seasons Hotel 57 East 57th Street New York, NY 10022
Welcome
Kathy Makrakis Vice President Investor Relations
Forward Looking Statement
Statements made in this presentation include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, including those relating to future financial expectations, involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward looking statements. Information on other significant potential risks and uncertainties not discussed herein may be found in the Company’s filings with the Securities and Exchange Commission including its Form 10K for the year ended December 31, 2005.
Webcast Information and Presentation Assumptions
Agenda
TOPIC
PRESENTERS
Welcome and Agenda
Kathleen Makrakis
Vice President Investor Relations
Company Overview
Ingrid Wiik
Vice Chairman, President and CEO
Financial Overview
Matthew Farrell
Executive Vice President and CFO
Animal Health
Carol Wrenn
President, Animal Health Division
Active Pharmaceutical Ingredients
Carl-Åke Carlsson
President, Active Pharmaceutical Ingredients
Break (10:15AM – 10:45AM)
Branded Pharmaceuticals
Ronald Warner
President, Branded Products
Joseph Stauffer
Vice President, Clinical Research & Medical Affairs
Wrap Up
Ingrid Wiik
Vice Chairman, President and CEO
Lunch (12:00PM)
Each Business Segment Session Will Include Time for Q&A
Company Overview
Ingrid Wiik Vice Chairman President and CEO
High Margin Businesses with Growth Opportunities
Specialty Pharmaceutical Businesses
Branded
Kadian®: extended release morphine product
Growing Kadian® prescriptions and market share
Active Pharmaceutical Ingredients
Fermentation and purification expertise
Animal Health
A worldwide leader in the treatment and prevention of diseases in food producing animals
AH 58